| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/08/1999 | WO1999033969A1 A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof in a vaccine |
| 07/08/1999 | WO1999033967A2 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 07/08/1999 | WO1999033954A1 Isolated strains of staphylococcus aureus and vaccines manufactured therefrom |
| 07/08/1999 | WO1999033940A1 Novel polymerizable fatty acids, phospholipids and polymerized liposomes therefrom |
| 07/08/1999 | WO1999033873A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
| 07/08/1999 | WO1999033872A1 Novel anti-hiv immunogens (toxoids), preparation methods and use for preventing and treating aids |
| 07/08/1999 | WO1999033869A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | WO1999033868A2 Human papillomavirus vaccine |
| 07/08/1999 | WO1999033853A2 Carbohydrates, useful in solid delivery systems |
| 07/08/1999 | WO1999033522A2 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancer |
| 07/08/1999 | WO1999033488A2 Adjuvanted vaccine formulation |
| 07/08/1999 | WO1999033484A1 Production process for intravenous immune serum globulin and resultant product |
| 07/08/1999 | WO1999033479A1 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/08/1999 | WO1999033475A1 Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications |
| 07/08/1999 | WO1999033346A1 Anti-retroviral immunogens, preparation and use |
| 07/08/1999 | WO1999020739A3 Novel lactic acid bacteria species |
| 07/08/1999 | WO1999020305A8 Veterinary vaccines |
| 07/08/1999 | WO1999018226A3 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 07/08/1999 | WO1999011275A9 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 07/08/1999 | WO1999004810A3 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 07/08/1999 | WO1999004265A9 Cancer associated nucleic acids and polypeptides |
| 07/08/1999 | CA2317120A1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancer |
| 07/08/1999 | CA2317111A1 Delivery of polypeptide-encoding plasmid dna into the cytosol of macrophages by attenuated suicide bacteria |
| 07/08/1999 | CA2317092A1 Isolated strains of staphylococcus aureus and vaccines manufactured therefrom |
| 07/08/1999 | CA2317029A1 A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof in a vaccine |
| 07/08/1999 | CA2316811A1 Anti-retroviral immunogens, preparation and use |
| 07/08/1999 | CA2316807A1 Novel polymerizable fatty acids, phospholipids and polymerized liposomes therefrom |
| 07/08/1999 | CA2316545A1 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 07/08/1999 | CA2316397A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | CA2316275A1 Carbohydrates, useful in solid delivery systems |
| 07/08/1999 | CA2316041A1 Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications |
| 07/08/1999 | CA2315790A1 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/08/1999 | CA2315617A1 Human signal peptide-containing proteins |
| 07/08/1999 | CA2315276A1 Human papillomavirus vaccine |
| 07/08/1999 | CA2281938A1 Production process for intravenous immune serum globulin and resultant product |
| 07/08/1999 | CA2240798A1 Method for induction of differentiation of osteoclasts |
| 07/07/1999 | EP0927763A2 Novel aroA |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927257A2 Human protein kinases |
| 07/07/1999 | EP0927256A1 Immunogenic peptides of foot-and-mouth disease viruses |
| 07/07/1999 | EP0927255A1 Vaccine production of the bacillus anthracis protective antigen |
| 07/07/1999 | EP0927244A1 Semi-allogeneic cell hybrids as preventive and therapeutic vaccines for cancer and aids |
| 07/07/1999 | EP0927045A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 07/07/1999 | EP0927024A2 Device and method for treating ophthalmic diseases |
| 07/07/1999 | EP0661985B1 Peptides capable of binding cd8 molecules on ctl precursors |
| 07/07/1999 | EP0637336B1 Mn gene and protein |
| 07/07/1999 | EP0571410B1 Herpes simplex virus-1 deletion variants and vaccines thereof |
| 07/07/1999 | EP0570381B1 Method for immobilization of thiol compounds via activation of polymers, activated polymers, and products obtained by the method |
| 07/07/1999 | EP0537166B1 Water-soluble polypeptides having high affinity for interferons alpha and beta |
| 07/07/1999 | CN1221880A In vitro method for determining presence of hepatocellular carcindoma |
| 07/07/1999 | CN1221879A In vitro method for determining presence of hepatocellular carcindoma |
| 07/06/1999 | US5919911 Monoclonal antibodies to stem cell factor receptors |
| 07/06/1999 | US5919904 Response regulator polypeptides; screening for bactericides |
| 07/06/1999 | US5919903 Low affinity human IL-12 beta2 receptor |
| 07/06/1999 | US5919896 PF4A receptor |
| 07/06/1999 | US5919692 Ubiquitous ATP-sensitive potassium-channel genes |
| 07/06/1999 | US5919687 Polynucleotide coding for neutral sphingomyelinase; for screening compounds for diagnosis and treatment of diseases; antiarthritic/antitumor/anticarcinogenic/anticholesterol agents; psychological/nervous system disorders |
| 07/06/1999 | US5919665 A soluble endotoxin-free recombinant fusion proteins used as immunogens; antitoxins for treatment of humans and animals |
| 07/06/1999 | US5919664 For screening for antibacterial compounds |
| 07/06/1999 | US5919663 Stable purA vectors and uses therefor |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919659 Polynucleotide |
| 07/06/1999 | US5919656 Genes encoding telomerase protein 1 |
| 07/06/1999 | US5919640 Streptococcus suis adhesin protein and method for producing it |
| 07/06/1999 | US5919620 Heat shock protein HSP72 of Streptococcus pneumoniae |
| 07/06/1999 | US5919616 Serological assay for herpes |
| 07/06/1999 | US5919615 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 07/06/1999 | US5919480 Liposomal influenza vaccine composition and method |
| 07/06/1999 | US5919466 Method for improving the yield of immunoantibodies in the vaccination of animals and humans |
| 07/06/1999 | US5919465 Methods for augmenting immunological responses through the administration of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) |
| 07/06/1999 | US5919464 Controlling cell differentiation |
| 07/06/1999 | US5919463 Inducing immune response in mammals |
| 07/06/1999 | US5919461 Nonpathogenic infectious bursal disease virus and vaccine |
| 07/06/1999 | US5919459 Compositions and methods for treating cancer and hyperproliferative disorders |
| 07/06/1999 | US5919458 Immunogen comprising particles of non-infectious human immunodeficieny virus having rna packaging defects in physiologically aceptable vehicle |
| 07/06/1999 | US5919457 Immunoconjugates comprising the monoclonal antibody txu-5/b53 linked to pokeweed antiviral protein or bioactive subunits thereof are provided which are effective for the treatment of mammalian hiv infection. |
| 07/06/1999 | US5919456 IL-13 receptor specific chimeric proteins |
| 07/06/1999 | US5919454 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications |
| 07/06/1999 | US5919453 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
| 07/06/1999 | US5919451 Feeding the animal feed particles having an inner core of nutrients and an outer layer containing a conjugated fatty acid or an antibody that can protect the animal from contacting diseases that can adversely affect the animal's |
| 07/06/1999 | CA2098397C Physiologically active substance designated as epimorphin, genes encoding the same, and antibodies thereto |
| 07/06/1999 | CA1340633C Method and therapeutic compositions for the treatment of myocardial infarction |
| 07/06/1999 | CA1340624C Modified vaccinia virus and methods for making and using the same |
| 07/05/1999 | WO1999038976A2 Human growth factor homologs |
| 07/05/1999 | CA2317812A1 Human growth factor homologs |
| 07/01/1999 | WO1999032645A1 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/01/1999 | WO1999032634A2 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | WO1999032633A1 Toxoplasma gondii proteins, corresponding nucleic acid molecules, and uses thereof |
| 07/01/1999 | WO1999032620A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | WO1999032610A1 Human nucleotide pyrophosphohydrolase-2 |
| 07/01/1999 | WO1999032520A1 Method for quantitating denatured ldls |
| 07/01/1999 | WO1999032148A1 Methods and compositions for inhibiting tumor cell growth |
| 07/01/1999 | WO1999032147A1 Immunization for ebola virus infection |
| 07/01/1999 | WO1999032146A1 Intranasal yellow fever vaccination |
| 07/01/1999 | WO1999032137A1 Lymphotactin as an adjuvant |
| 07/01/1999 | WO1999032133A1 Methods and compositions for the treatment and prevention of staphylococcus aureus infections |
| 07/01/1999 | WO1999025832A8 Toso |
| 07/01/1999 | DE19758400A1 Tumorvakzine für MUC1-positive Karzinome Tumor vaccine for MUC1-positive carcinomas |
| 07/01/1999 | DE19757250A1 Insulin-like growth factor binding protein und seine Verwendung Insulin-like growth factor binding protein and its use |
| 07/01/1999 | CA2316323A1 Lymphotactin as an adjuvant |